A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is application/pdf
.
A Retrospective Analysis of Therapeutic Inertia in Type 2 Diabetes Management Across a Diverse Population of Health Care Organizations in the USA
2021
Diabetes Therapy
If their target glycated hemoglobin (HbA1c) is not achieved after 3 months, timely treatment intensification is recommended in people with type 2 diabetes to maintain glycemic control and minimize vascular complications. We retrospectively investigated potential therapeutic inertia in the management of type 2 diabetes in multiple health care organizations across the USA. Electronic health records were analyzed from 22 American Medical Group Association (AMGA) health care organizations. Bolus
doi:10.1007/s13300-020-00993-w
pmid:33460018
pmcid:PMC7846632
fatcat:xje4dky5drgltpermqdsg3bubm